Avalyn
Investment area
Venture Investments
Region
North America
Date of investment
February 2017
Avalyn is a virtual pharmaceutical company developing an improved therapy for the treatment of Idiopathic Pulmonary Fibrosis (IPF).
Investment area
Venture Investments
Region
North America
Date of investment
February 2017
Avalyn is a virtual pharmaceutical company developing an improved therapy for the treatment of Idiopathic Pulmonary Fibrosis (IPF).